Page 126 - 《中国药房》2024年4期
P. 126

基于患者疾病自我管理能力的下肢动脉疾病药学服务模式的构建                                                                      Δ



                                   2
                           2
                                           1 #
                 1*
          江书正 ,陈 熙 ,陈飞宇 ,张韶辉 (1.武汉市第一医院药学部,武汉 430022;2.武汉市第一医院血管外科,
          武汉 430022)
          中图分类号  R969.3      文献标志码  A      文章编号  1001-0408(2024)04-0500-06
          DOI  10.6039/j.issn.1001-0408.2024.04.22

          摘   要  目的  构建下肢动脉疾病(LEAD)患者院内药学监护+院外药学门诊一体化服务模式,提高患者的疾病自我管理能力及
          疾病治疗的有效性和安全性。方法  构建LEAD患者院内药学监护及院外药学门诊服务模式(包含药学评估、自我管理能力宣教、
          药学随访),对患者进行长期管理。选取2021年9月-2022年12月在我院血管外科住院或门诊就诊并经药师管理的65例LEAD
          患者为研究对象,由药师进行院内药学监护+院外门诊持续管理,比较经药师管理3个月前后疾病治疗有效性指标、安全性指标
          和患者疾病自我管理能力指标。结果  65例患者经药师管理3个月后,55例患者Fontaine分期降低,管理前后Fontaine分期差异有
          统计学意义(P<0.001);完全遵循指南用药的患者占比由63.1%提升至96.9%,小出血发生率减少7.7%,患者Morisky用药依从性
          评分和疾病自我管理能力评分显著提高(P<0.001),就医满意度为“好”的患者占比增加了18.4%。结论  LEAD患者院内外一体
          化药学服务模式可有效提高患者疾病自我管理能力,提高患者疾病治疗的有效性及安全性。
          关键词  下肢动脉疾病;疾病自我管理能力;药学服务;药学门诊


          Establishment  of  pharmaceutical  care  model  for  lower  extremity  artery  disease  based  on  patients’  disease
          self-management ability
                                                 2
                                                                  1
                                    2
                         1
          JIANG Shuzheng ,CHEN Xi ,CHEN Feiyu ,ZHANG Shaohui(1.  Dept.  of  Pharmacy,  Wuhan  No.1  Hospital,
          Wuhan 430022, China;2. Dept. of Vascular Surgery, Wuhan No.1 Hospital, Wuhan 430022, China)
          ABSTRACT    OBJECTIVE  To  construct  the  integrated  pharmaceutical  care  model  of  in-hospital  pharmaceutical  care+out-hospital
          pharmacy  outpatient  service  for  patients  with  lower  extremity  artery  disease (LEAD),  so  as  to  improve  patients’  disease  self-
          management  ability,  and  the  efficacy  and  safety  of  therapy.  METHODS  The  in-hospital  pharmaceutical  care  and  out-hospital
          pharmacy  outpatient  service  model  was  constructed  for  LEAD  patients,  including  pharmaceutical  evaluation,  self-management
          ability education, and pharmacy follow-up, to perform long-term management of patients. Totally 65 LEAD patients admitted to the
          vascular  surgery  department  of  our  hospital,  receiving  pharmacist  management,  from  September,  2021  to  December,  2022  were
          selected  as  the  study  objects,  and  pharmacists  conducted  in-hospital  pharmaceutical  care+continuous  out-patient  management.  The
          efficacy  indicators,  safety  indicators,  and  patients’s  disease  self-management  ability  indicators   were  compared  before  and  after  3
          months  of  pharmacist  management.  RESULTS  After  3  months  of  pharmacists’  participation  in  the  management  of  65  patients,
          Fontaine  stage  decreased  in  55  patients,  there  was  the  significant  difference  in  Fontaine  stage  before  and  after  management (P<
          0.001).  The  proportion  of  patients  who  completely  followed  the  guidelines  for  medication  increased  from  63.1%  to  96.9%;  the
          incidence  of  small  bleeding  was  reduced  by  7.7%  after  pharmacists’  management.  The  scores  of  Morisky  medication  compliance
          and  patients’  disease  self-management  ability  were  higher  than  3  months  ago (P<0.001).  Patient  proportion  with “good”  medical
          satisfaction increased by 18.4%. CONCLUSIONS The in-hospital pharmaceutical care and out-hospital pharmacy outpatient service
          model of LEAD patients can effectively improve patients’ disease self-management ability, and improve the efficacy and safety of
          therapy.
          KEYWORDS     lower extremity artery disease; disease self-management ability; pharmaceutical care; pharmaceutical clinic


              下 肢 动 脉 疾 病(lower  extremity  artery  disease,  LEAD)是外周动脉疾病(peripheral artery disease,PAD)
                                                              最主要的疾病表现形式,是指因下肢动脉硬化狭窄闭塞
              Δ 基金项目 湖北省卫生健康委科研项目(No.WJ2023M125);湖
          北省卫生健康委联合基金项目(No.WJ2019H234,No.WJ2019H229)          导致的肢体缺血疼痛甚至坏死。我国 35 岁及以上的成
             *第一作者 主管药师,硕士。研究方向:临床药学。E-mail:                  年人中有6.6%(估计为4 530万)患有PAD,75岁后PAD
          691054072@qq.com
                                                                              [1]
                                                              的患病率显著增加 。PAD 是仅次于冠心病、脑卒中的
              # 通信作者 副主任药师,博士。研究方向:临床药学、合理用药管
          理。E-mail:53685340@qq.com                            第三大动脉粥样硬化性心血管疾病,可导致脑卒中、冠

          · 500 ·    China Pharmacy  2024 Vol. 35  No. 4                               中国药房  2024年第35卷第4期
   121   122   123   124   125   126   127   128   129   130   131